All terms in GO
| Label | Id | Description |
|---|---|---|
| positive regulation of transporter activity | GO_0032411 | [Any process that activates or increases the activity of a transporter.] |
| receptor localization to synapse | GO_0097120 | [Any process in which a receptor is transported to, and/or maintained at the synapse, the junction between a nerve fiber of one neuron and another neuron or muscle fiber or glial cell.] |
| cyclin A1-CDK1 complex | GO_0097121 | [A protein complex consisting of cyclin A1 and cyclin-dependent kinase 1 (CDK1). Cyclins are characterized by periodicity in protein abundance throughout the cell cycle. Cyclin-dependent kinases represent a family of serine/threonine protein kinases that become active upon binding to a cyclin regulatory partner.] |
| negative regulation of fibroblast apoptotic process | GO_2000270 | [Any process that stops, prevents or reduces the frequency, rate or extent of fibroblast apoptotic process.] |
| cyclin A2-CDK1 complex | GO_0097122 | [A protein complex consisting of cyclin A2 and cyclin-dependent kinase 1 (CDK1). Cyclins are characterized by periodicity in protein abundance throughout the cell cycle. Cyclin-dependent kinases represent a family of serine/threonine protein kinases that become active upon binding to a cyclin regulatory partner.] |
| positive regulation of fibroblast apoptotic process | GO_2000271 | [Any process that activates or increases the frequency, rate or extent of fibroblast apoptotic process.] |
| cyclin A1-CDK2 complex | GO_0097123 | [A protein complex consisting of cyclin A1 and cyclin-dependent kinase 2 (CDK2). Cyclins are characterized by periodicity in protein abundance throughout the cell cycle. Cyclin-dependent kinases represent a family of serine/threonine protein kinases that become active upon binding to a cyclin regulatory partner.] |
| cyclin A2-CDK2 complex | GO_0097124 | [A protein complex consisting of cyclin A2 and cyclin-dependent kinase 2 (CDK2). Cyclins are characterized by periodicity in protein abundance throughout the cell cycle. Cyclin-dependent kinases represent a family of serine/threonine protein kinases that become active upon binding to a cyclin regulatory partner.] |
| cyclin B1-CDK1 complex | GO_0097125 | [A protein complex consisting of cyclin B1 and cyclin-dependent kinase 1 (CDK1). Cyclins are characterized by periodicity in protein abundance throughout the cell cycle. Cyclin-dependent kinases represent a family of serine/threonine protein kinases that become active upon binding to a cyclin regulatory partner.] |
| cyclin B2-CDK1 complex | GO_0097126 | [A protein complex consisting of cyclin B2 and cyclin-dependent kinase 1 (CDK1). Cyclins are characterized by periodicity in protein abundance throughout the cell cycle. Cyclin-dependent kinases represent a family of serine/threonine protein kinases that become active upon binding to a cyclin regulatory partner.] |
| cyclin B3-CDK2 complex | GO_0097127 | [A protein complex consisting of cyclin B3 and cyclin-dependent kinase 2 (CDK2). Cyclins are characterized by periodicity in protein abundance throughout the cell cycle. Cyclin-dependent kinases represent a family of serine/threonine protein kinases that become active upon binding to a cyclin regulatory partner.] |
| cyclin D1-CDK4 complex | GO_0097128 | [A protein complex consisting of cyclin D1 and cyclin-dependent kinase 4 (CDK4). Cyclins are characterized by periodicity in protein abundance throughout the cell cycle. Cyclin-dependent kinases represent a family of serine/threonine protein kinases that become active upon binding to a cyclin regulatory partner.] |
| cyclin D2-CDK4 complex | GO_0097129 | [A protein complex consisting of cyclin D2 and cyclin-dependent kinase 4 (CDK4). Cyclins are characterized by periodicity in protein abundance throughout the cell cycle. Cyclin-dependent kinases represent a family of serine/threonine protein kinases that become active upon binding to a cyclin regulatory partner.] |
| inactivation of MAPK activity | GO_0000188 | [Any process that terminates the activity of the active enzyme MAP kinase.] |
| negative regulation of MAP kinase activity | GO_0043407 | [Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity.] |
| obsolete MAPK import into nucleus | GO_0000189 | [OBSOLETE. The directed movement of a MAP kinase to the nucleus upon activation.] |
| positive regulation of MAP kinase activity | GO_0043406 | [Any process that activates or increases the frequency, rate or extent of MAP kinase activity.] |
| MAP kinase kinase activity | GO_0004708 | [Catalysis of the concomitant phosphorylation of threonine (T) and tyrosine (Y) residues in a Thr-Glu-Tyr (TEY) thiolester sequence in a MAP kinase (MAPK) substrate.] |
| nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | GO_0000184 | [The nonsense-mediated decay pathway for nuclear-transcribed mRNAs degrades mRNAs in which an amino-acid codon has changed to a nonsense codon; this prevents the translation of such mRNAs into truncated, and potentially harmful, proteins.] |
| MAP kinase kinase kinase activity | GO_0004709 | [Catalysis of the phosphorylation and activation of a MAP kinase kinase; each MAP kinase kinase can be phosphorylated by any of several MAP kinase kinase kinases.] |